Using the common cold virus as a naturally occurring vaccine to prevent COVID-19

By Joanie in Lastest News on 16 October 2020

New research from the lead scientific advisor of the Healthy Life Foundation, Michael Lisanti and his team at Salford University.

Three recent papers published in Nature, Science and Cell, all present clear evidence that there is cross-reactive T-cell immunity between human coronaviruses (229E, NL63, OC43, and HKU1), linked with the common cold, and SARS-CoV-2, the causative agent of COVID-19. Can we use this information to design and build a new vaccine based on the less pathogenic, common cold coronaviruses, for the prevention of COVID-19? If we look at the history of medicine and vaccine development, from the point of view of Edward Jenner, the answer just might be yes.

Click on the link below to read the full article:

https://www.aging-us.com/article/5f85b99ce798ca0008c1366a/text